Memantine vs Semax-Amidate

Overview

Memantine and Semax-Amidate are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Memantine and Semax-Amidate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Memantine is categorised under Cognitive Enhancement, while Semax-Amidate falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Memantine: not FDA-approved; treated as a research compound. Semax-Amidate: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Memantine is typically dosed at 5-20 mg (daily). Semax-Amidate is typically dosed at 300-600 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Memantine and Semax-Amidate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Memantine and Semax-Amidate?

Memantine and Semax-Amidate are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Memantine is not FDA-approved; generally classified as a research compound, whereas Semax-Amidate is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is Memantine used for?

NMDA antagonist.

What is Semax-Amidate used for?

Extended release Semax.

Can you take Memantine and Semax-Amidate together?

Some users combine peptides within a single protocol, but stacking Memantine and Semax-Amidate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Memantine or Semax-Amidate FDA-approved?

Memantine is not FDA-approved; generally classified as a research compound. Semax-Amidate is not FDA-approved; compounding permitted with a prescription (as of April 2026).